EI

Eiger BioPharmaceuticals

- NASDAQ:EIGR
Last Updated 2024-04-16
  • Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis.

  • Locations

    • 350 Cambridge Ave Ste 350, Palo Alto CA
    • San Carlos CA

  • Total Funding (USD)

    48.1 million

  • Industries

    Real Estate, Mobile Apps, Video Games, Cyber Security, Drones, Software

  • Acquisitions (1)

    • Celladon (2015)

  • Security

    Type: ORD
    CUSIP: 28249U105
    ISIN: US28249U1051
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo